EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Choosing the proper anti arrhythmic therapy


Archivos del Instituto de Cardiologia de Mexico 60(5): 479-484
Choosing the proper anti arrhythmic therapy
Here are described the topics that we think are essentials in the anti-arrhythmia drug selection. Those factors are the substract, the threshold and the modulator factors. Are also included the place were anti-arrhythmia agents acts, their general actions, their failure and finally the basis of the combined therapy.

(PDF 0-2 workdays service: $29.90)

Accession: 007111776



Related references

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. Europace 10(6): 647-665, 2008

Present status in and prospects for anti-arrhythmic drug therapy: Classification of anti-arrhythmic agents and electrophysiology. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 95(2): 240-245, 2006

Present status in and prospects for anti-arrhythmic drug therapy: How to use type III anti-arrhythmic agents. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 95(2): 253-260, 2006

Anti-arrhythmic agents. 1. anti-arrhythmic agents, indications, counter-indications side effects; dosage, methods of application; differential therapy. Fortschritte der Medizin 98(14): 519-525, 1980

General principles in choosing the anti arrhythmic preparation and the tactics of treating patients with disturbances of cardiac rhythm. Klinicheskaya Meditsina (Moscow) 60(5): 68-72, 1982

Present status in and prospects for anti-arrhythmic drug therapy: Drug therapy for arrhythmic patients with heart failure, kidney failure, liver dysfunction or in pregnancy. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 95(2): 261-270, 2006

Topical therapy: choosing and using the proper vehicle. Nursing 7(11): 8-10, 1977

Pharmacology of a new anti arrhythmic agent if rom 203 n n bis 2 hydroxy 3 phenoxypropyl ethylenediamine di hydro chloride part 2 anti arrhythmic properties. Dissertationes Pharmaceuticae et Pharmacologicae 24(2): 113-126, 1972

Relationship between anti arrhythmic activity and direct cardiac effects in class i anti arrhythmic compounds. Pharmacologist 22(3): 160, 1980

Anti-arrhythmic efficacy of nifekalant hydrochloride, a pure class III anti-arrhythmic agent, in patients with healed myocardial infarction and inducible sustained ventricular tachycardia. Journal of Cardiovascular Pharmacology 40(5): 735-742, 2002